National RX SecurityWorking Together For A Better Community
National RX SecurityNational RX Security ProductsNational RX SecurityOrder National RX Security ProductsNational RX SecurityNational RX Security Advertising OpportunitiesNational RX Security New ProductsContact National RX Security
National RX Security
National RX Security Latest News National RX Security Blog
National RX Security Videos

We ship in 24-48 hours.

Your order will leave our factory by FedEx ground, 2 business days after receipt of your completed order.

 

NEW JERSEY STATE RX PAD EXTENSION

The state of NJ has made a final extension to the deadline for all prescribers to begin using new prescription pads until NOVEMBER 3, 2014.

 

Our scripts meet and exceed all Federal and all individual State requirements, for Medicaid* (*except KY, IN, NY)

National RX Security FL Approved

National RX Security NJ Approved

National RX Security Washington Approved

National RX Security WY Approved

Script Shield CA Approved

FDA Warns of Counterfeit Botox Found in the US   May . 4 . 2015

The Food and Drug Administration (FDA) recently announced that a counterfeit version of Botox has been found in the United States. The product, which may have been sold to offices and clinics nationwide, was sold by an unlicensed, unauthorized supplier. The FDA warns healthcare providers against using these unverified drugs, and provides a way to easily identify if a batch is from this unlicensed provider.

According to the FDA Drug Safety Alert, “the counterfeit product can be identified by one or more of the following:
- the vial is missing the lot number
- the outer carton does not have any entries next to the LOT: MFG: EXP:
- the outer carton and vial display the active ingredient as ‘Botulinum Toxin Type A’ instead of ‘OnabotulinumtoxinA’ ”

Please note that, at present, there is no reason to believe that Allergan’s FDA-approved Botox is at risk, and “the genuine product should be considered safe and effective for its intended and approved uses.” Suspicious packages of Botox should be reported to the FDA’s Office of Criminal Investigations.

For more information, and to stay up to date with Drug Safety Alerts, please visit www.fda.org.

Information for this blog post was sourced from NABP e-News and the FDA Drug Safety Alert. For more information about the National Association Board of Pharmacy, please visit www.nabp.net.

 

 

National RX Security
Home   |   Our Product   |   Order/Pricing    |   Order by Fax/Mail   |   Pharmaceutical Advertising Opportunities   |   New Product   |   Contact Us

Copyright © McCaffery & Associates, Inc.   ::    Site Map   ::